Major depressive disorder has been ranked as the third cause of the burden of disease worldwide, according to the World Health Organization.
Disease burden looks at the impact of a health problem by its mortality and money losses.
The burden is also prompting people to look at new ways to cope. One of those is microdosing psychedelic mushrooms, also known as psilocybin.
“When you're working with a microdose, you can drive, go to work, you can parent and do all the typical roles and responsibilities of your daily life,” said psychotherapist Brooke Novick.
Although some users are reporting it makes them feel more present, some doctors say there is not much research on the effect of microdosing psilocybin.
Most studies that show the drug may help treat depression focus on a single large dose. Doctors add there are indications that repeated use could cause heart problems.
”The science is is yet to catch up with this practice that people seem to be doing quite a lot out there in the world,” said Dr. Natalie Gukasyan, director of the Johns Hopkins Center for Psychedelic Research.
Gukasyan said the drug has the potential to treat disorders from depression to Alzheimer’s. She added it could be a better option for some people than other medications.
“But right now, we're still working on getting that the data from all these larger studies that shows that yeah, on average over a large number of people, this is indeed safe and effective relative to the risks that might be involved,” Gukasyan said.
She cautions that if you’re microdosing, there is a risk of taking too much, which could impair your daily tasks.
